MedTrace Logo

A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis

NCT01328015 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2011-04-04

No results posted yet for this study

Summary

A study in which the experimental treatment procedure is compared to a standard (control) treatment, The use of oxybutynin in the late postoperative thoracic sympathectomy for women:

1. To Evaluate the effect of oxybutynin on plantar hyperhidrosis.
2. To evaluate the effect of oxybutynin in compensatory hyperhidrosis.
3. To compare the results of questionnaires on quality of life and specific for hyperhidrosis to the results of TEWL.

Conditions

  • Hyperhidrosis

Interventions

DRUG

Oxybutynin 5 mg pills

½ pill oral 12/12h for 3 days 01 ½ pills oral morning and evening for 3 days Continue 1 pill oral 2x/day for three weeks.

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Altair S Costa Jr, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-05-31
Completion
2010-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01328015 on ClinicalTrials.gov